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We examined the effects of human purified interleukin-1 (IL-l) on DNA synthesis, cell growth, and alkaline 
phosphatase activity in the osteoblastic ell line MC3T3-El under both preconfluent and confluent culture 
conditions. Addition of IL-l to the cells markedly inhibited their DNA synthesis and growth over the range 
l-10 U/ml. Such significant inhibitory effects were observed in cells cultivated in 1 or 5% fetal calf serum 
(FCS)-containing alpha modification Eagle’s medium (alpha-MEM), but not in alpha-MEM containing 
10% FCS. In contrast, alkaline phosphatase activity was enhanced significantly by IL-l in the cell line culti- 
vated in 1% FCS-containing alpha-MEM. These results demonstrate that human purified IL-l is effective 
in inducing the differentiation of osteoblastic ell MC3T3-E 1. 
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1. INTRODUCTION 
Some recent studies have suggested that 
macrophage-derived interleukin-1 (IL-l), a peptide 
hormone, may be involved in the regulatory 
mechanisms at play in the bone remodeling system 
[l-5]. Gowen et al. [l] have shown that a human 
monocyte-derived IL-l-like factor stimulates bone 
resorption. It has been reported that IL-1 inhibits 
the production of the bone specific protein 
osteocalcin in human osteoblast-like cells [3]. 
Also, Krakauer et al. [4] have shown that human 
IL-1 mediates cartilage matrix degradation. In- 
terestingly, a very recent study [6] has 
demonstrated that human recombinant IL-l P is 
the major protein with osteoclast-activating factor 
activity produced by lectin-stimulated human 
peripheral blood mononuclear cells. 
Although many studies have shown effects of 
several hormones on cell growth, collagen syn- 
thesis, and alkaline phosphatase activity of 
osteoblast-like cells, it is also very important to 
understand the effect of IL-1 on the biological ac- 
tivities in osteoblastic cells for elucidation of its 
regulatory mechanisms in the bone remodeling 
process. 
We have now investigated the effect of IL-l or 
IL-l-like factor on the bone remodeling process. 
Because bone remodeling is regulated by interac- 
tions among bone cells, macrophages, lym- 
phocytes, and their products, it is very important 
to use a clonal bone cell population and 
homogeneous IL-1 for analysis of the functional 
role of IL-l in the bone remodeling process. 
Kodama et al. [7] have recently established aclonal 
osteoblastic cell line (MC3T3-El) from newborn 
mouse calvaria, and this cell line exhibits various 
osteoblastic functions [8). Here, we examined the 
effect of human purified IL-l on some parameters 
of differentiation, such as DNA synthesis, cell 
growth, and alkaline phosphatase activity in this 
clonal osteoblastic cell line. 
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The results show that human purified IL-l is ef- 
fective in inducing the differentiation of clonal 
osteoblastic cells. 
2. MATERIALS AND METHODS 
2.1. Osteoblastic ell line 
The MC3T3-El cell line, derived from C57BL/6 
newborn mouse calvaria, was kindly provided by 
Dr Kodama (Tohoku Dental University, 
Fukushima). The cells were grown in 10% fetal 
calf serum (FCS, Irvine Scientific, Santa Ana, 
USA)-containing the alpha modification Eagle’s 
medium (alpha-MEM, Flow Labs, McLean, USA) 
supplemented with antibiotics. The cells were 
maintained at 37°C in 5% CO2 in air. Cells were 
passaged twice a week by treatment with 0.02% 
pronase and 0.02% EDTA in Mg’+- and Ca2+-free 
phosphate-buffered saline. 
2.2. Assay for DNA synthesis and cell growth 
MC3T3-E 1 cells were seeded into Falcon 96-well 
flat-bottomed type microculture plates (5 x lo3 
cells/well) and incubated overnight in 200~1 of 
10% FCS-containing alpha-MEM. In some ex- 
periments, the cells were incubated until the 
monolayer had reached confluence. These cells 
were washed twice with alpha-MEM, and then 
100~1 of various doses of human ultrapure IL-l 
(Genzyme, Boston, USA) was added to each well, 
along with 100 ~1 of 1% FCS-containing alpha- 
MEM, unless stated otherwise. After 48 h, the cells 
were pulsed for 16 h with 0.2&i [‘4C]thymidine 
(spec. act. 50.5 mCi/ml, New England Nuclear, 
Boston, USA) and then washed twice with 
phosphate-buffered saline. The washed cells were 
treated with 0.2% SDS, and the radioactivities in 
the lysate were measured by liquid scintillation 
counting. The number of [14C]thymidine counts in 
the SDS lysate was similar to that found in the 
trichloroacetic acid-insoluble material. 
To determine the effects of IL-l on the growth 
of MC3T3-El cell, the cells in alpha-MEM con- 
taining 10% FCS were seeded into wells of Falcon 
24-well flat-bottomed type microculture plates (8 x 
lo3 cells/well) and incubated overnight. The 
culture medium was then removed and replaced 
with alpha-MEM containing 1% FCS, and various 
concentrations of IL-l. At chosen intervals during 
the following culture period, cells were treated 
280 
with 0.02% pronase, and the dispersed cells were 
counted in a hemocytometer. The experiments 
were carried out with triplicate cultures and the 
results expressed as mean cell number f SD. 
2.3. Assay for alkaline phosphatase activity 
MC3T3-El cells were seeded in Falcon 96-well 
flat-bottomed type microculture plates (5 x lo3 
cells/well), and cultured in 10% FCS-containing 
alpha-MEM until the cell monolayer had reached 
confluence. The cultured cells were washed twice 
with alpha-MEM and then cultured for various 
times in alpha-MEM with or without serum and 
various concentrations of IL-l. The IL-l-treated 
cells were then washed twice with phosphate- 
buffered saline, followed by the addition of 200 ~1 
of 0.2% Nonidate P-40 containing 1 mM MgClz to 
the cells. Thereafter, the cells were sonicated for 
5 s with a Branson model 200 ultrasonifier. The 
lysate was used for the assay of alkaline 
phosphatase activity. Alkaline phosphatase activi- 
ty was measured as described by Lowry et al. [9] 
with p-nitrophenyl phosphate as substrate. Protein 
content was measured by the dye-binding method 
of Bradford [lo]. 
2.4. Assay for IL-l activity 
IL-l activity was measured as described [ll]; 
briefly, C3H/HeJ mouse thymocytes (1.5 x lo6 
cells/well) were cultured for 72 h at 37°C in 5% 
FCS-containing RPM1 1640 (Nissui Phar- 
maceutical, Tokyo) supplemented with 2-mercap- 
toethanol and phytohemagglutinin-p (Difco, 
Detroit) and test sample. Cell proliferation was 
measured by pulsing with 0.5 ,&i [3H]thymidine 
(New England Nuclear, spec. act. 6.7 Ci/mM) for 
the last 24 h of the culture period. The results were 
expressed as the arithmetic mean of cpm + SD as 
determined from triplicate cultures. 
3. RESULTS 
Figs 1 and 2 show that addition of purified IL-l 
to preconfluent monolayers of MC3T3-El cells 
markedly inhibited DNA synthesis and cell 
growth. DNA synthesis decreased to 42% of the 
control value when the cells were treated with 
1 U/ml of IL-l. Also, cell growth was significantly 
inhibited as early as 24 h after initiation of treat- 
ment with 1 or 5 U/ml of IL-l. However, signifi- 
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Fig.1. Effect of purified IL-1 on DNA synthesis 
in MC3T3-El cells under preconfluent cultures. 
MC3T3-El cells were plated in 96-well flat-bottomed 
type culture plates (5 x IO3 cells/well) in 1% FCS- 
containing alpha-MEM with or without IL-l at various 
concentrations. After 48 h, the cells were pulsed for 16 h 
with 0.2 pCi [14CJth~idine. The results are expressed as 
mean f SD from triplicate cultures. * Significant 
difference from control at p < 0.01. 
cant inhibitory effect at 1 U/ml was not observed 
at 72 h after its addition. Fig.3 shows that alkaline 
phosphatase activity of the cells cultured with 
1 U/ml of IL-l was enhanced in a time-dependent 
manner. 
The inhibitory effect of IL-l on DNA synthesis 
of the cells in media supplemented with different 
serum concentrations was also examined (fig.4). 
No significant inhibitory activity with IL-l at 
5 U/ml was detected in the cells cultivated in 
alpha-MEM containing 10% FCS. However, IL-l 
remarkably inhibited DNA synthesis of the cells 
cultivated in alpha-MEM containing 1% FCS. 
These results indicate that some factor(s) con- 
tained in the serum affects the action of IL-l on 
DNA synthesis and cell growth in this cell line. 
These results led us to suppose that IL-l may be 
actively involved in the differentiation of 
MC3T3-E 1 cells under preconfluent culture condi- 
tions. Therefore, we further examined IL-1 for a 
possible effect on the differentiation of these cells 
under confluent culture conditions by assaying for 
their DNA synthesis and alkaline phosphatase ac- 
tivity. The cells were seeded at a density of 5 x lo3 
cells/well into Falcon 96-well flat-bottomed type 
microculture plates. After cell monolayers had 
reached confluence, the cells were incubated for 4 
days in serum-free alpha-MEM and various doses 
of IL-l. As shown in fig.5, significant enhance- 
ment of alkaline phosphatase activity was observed 
in the cells cultivated in the presence of 5 U/ml of 
IL-l. However, the cellular protein content per 
- 
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Fig.2. Effect of purified IL-l on growth of MC3T3-El cells. The cells were plated in 24-well flat-bottomed type culture 
plates (8 x IO3 cells/well) in 1% FCS-containing alpha-MEM with or without IL-I at various concentrations. (a) After 
72 h the medium was removed and the cells treated with pronase and then counted. Each point represents the mean + 
SD of triplicate cultures. * Significant difference from control at p < 0.01. (b) Cells were cultured with 1 U/ml (0) or 
5 U/ml (0) of IL-l. At various intervals, some of the cells were treated with pronase and then counted. The results are 
expressed as % inhibition by IL-l (treated/untreat~ cells). Each point represents the mean + SD of triplicate cultures. 
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Fig.3. Effect of purified IL-l on alkaline phosphatase 
activity of MC3T3-El cells. MC3T3-El cells were plated 
in 96-well flat-bottomed type culture plates (5 x lo3 
cells/well) in 1% FCS containing alpha-MEM with (0) 
or without (0) IL-l at 1 U/ml. After each culture 
period, the cells were assayed for alkaline phosphatase 
activity. The results are expressed as the mean + SD of 
triplicate cultures. * Significant difference from control 
at p < 0.01. 
culture was not affected under the same condi- 
tions. On the other hand, remarkable inhibition of 
DNA synthesis was found in cells treated with IL-l 
at the same concentrations. The inhibition of DNA 
synthesis occurred in a dose-dependent fashion 
over the concentration range l-10 U/ml. 
These findings show that the IL-l is an effective 
mediator for inducing clonal osteoblastic cell dif- 
ferentiation in vitro. 
4. DISCUSSION 
This paper reports that purified IL-l is effective 
in inducing the differentiation of clonal 
osteoblastic cell lines (MC3T3-El), which were 
derived from newborn mouse calvaria. The effects 
of this cytokine on some parameters of differentia- 
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Fig.4. Effect of serum on DNA synthesis of MC3T3-El 
cells treated with IL-l. Cells were plated in 96-well flat- 
bottomed type culture plates (5 x lo3 cells/well) in 
alpha-MEM containing various concentrations of FCS 
with ( ) or without ( ) 5 U/ml of IL-l. After 
48 h, cells were pulsed for 16 h with 0.2,&i 
[‘4C]thymidine, and the radioactivity measured. Each 
point represents the mean + SD of triplicate cultures. 
* Significant difference from control at p < 0.01. 
tion, such as DNA synthesis, cell growth, and 
alkaline phosphatase activity, were examined in 
this osteoblastic ell line. IL-l inhibited DNA syn- 
thesis and cell growth of the cells, but enhanced 
their alkaline phosphatase activity. Sudo et al. [8] 
have demonstrated that MC3T3-El cells exhibit 
properties of osteoprogenitor cells in their active 
growing stage and have the capacity to differen- 
tiate into osteoblasts and osteocytes in vitro. Our 
present findings show that purified IL-l can act as 
an agent for differentiation of these cells in vitro. 
Very recently, Gowen et al. [12] have shown that 
human monocyte products with IL-l activity 
stimulate proliferation of human bone cells. Since 
they have no evidence that the stimulatory factor 
is IL-l, nor do they know which cell types respond 
to the stimulatory effect, identification of the 
monocyte products and their target cells has yet to 
be made. The answers are very important for an 
understanding of the regulatory role of monocyte- 
and macrophage-derived factors in the bone 
remodeling process. 
IL-l has been recently recognized as a polypep- 
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tide hormone produced by activated macrophages. 
Dower et al. [13] have shown that IL-l receptor(s) 
distributed on T and B lymphocytes, fibroblasts, 
and epithelial cells, and have suggested that the ap- 
parently diverse biological activities of IL-l are 
presumably mediated by its specific cell surface 
receptor(s). Although we have not yet determined 
whether the IL-l receptor(s) is present on 
osteoblastic MC3T3-El cells, it is a very attractive 
proposal that some of the effects of IL-l on DNA 
Fig.5. Effect of IL-l on DNA synthesis and alkaline 
phosphatase activity of MC3T3-El cells under confluent 
culture conditions. Cells were cultured in 96-well flat- 
bottomed type culture plates (5 x lo3 cells/well) with 
10% FCS-containing alpha-MEM. After the cell 
monolayer had reached confluence, cells were cultured 
in serum free alpha-MEM with or without IL-l. For 
assay of DNA synthesis, after 3 days the cells were 
pulsed for 16 h with 0.2 pCi [14C]thymidine and then the 
radioactivity in the cells counted. On the other hand, for 
alkaline phosphatase activity, the cells were cultured for 
4 days and then assayed for enzyme activity. Results are 
expressed as the mean + SD of triplicate cultures. (a) 
IL-l activity, (b) DNA synthesis ([‘4C]thymidine uptake 
dpm/culture), (c) alkaline phosphatase activity (U/mg 
protein), (d) protein concentration (ug/culture). 
* Significant difference from control at p < 0.01. 
synthesis, cell growth, and/or alkaline phos- 
phatase activity in MC3T3-El may result from in- 
teraction between IL-l and its receptor on the cells. 
Recent studies [l, 141 have shown that both 
human and pig IL-l-like factors stimulate bone 
resorption. Interestingly, Dewhirst et al. [6] have 
indicated that human recombinant IL-lb is the ma- 
jor protein with osteoclast-activating factor activi- 
ty produced by lectin-stimulated peripheral blood 
mononuclear cells. Therefore, it is clear from these 
findings that IL-1 plays a regulatory role in the 
bone remodelling process. 
The role played by IL-l in the regulation of bone 
remodeling is unclear. However, further studies 
employing recombinant IL- 1 and these MC3T3-E 1 
clonal osteoblasts should lead to a better 
understanding of the regulatory mechanisms 
underlying the bone remodeling process. 
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